Contents
Editor’s Letter
Introduction to the GaBI Journal
Editorial
Generic medicine pricing: on track in Europe?
Commentary
Innovator companies should focus on innovations
Review Article
A review of generic medicine pricing in Europe
Biologicals and biosimilars: a review of the science and its implications
A patient-centred paradigm for the biosimilars market
European payer initiatives to reduce prescribing costs through use of generics
Perspective
Myths, questions, facts about generic drugs in the EU
Generic and therapeutic orphans
Special Report
How matrix models can support generic medicine prescribing
Rhythm